Literature DB >> 3240764

Pharmacokinetics of the dopamine partial agonist, terguride, in the rat and rhesus monkey.

W Krause1, M Hümpel.   

Abstract

3H-labelled terguride was rapidly and completely absorbed in the rat after oral administration of up to 50 mg/kg. In the rhesus monkey, absorption was prolonged. The bioavailability of terguride was 79% in the rat and 15% in the monkey. Plasma levels of the unchanged drug declined with a half-life of 50 min (rat) or 20 min (monkey). Tissue distribution as studied by autoradiography in pregnant rats showed highest concentrations of labelled compounds in the liver, the cervical gland and the kidney. Lower levels were found in the thymus, the spinal cord, the placenta and the heart muscle followed by the fetal tissue, the muscles and the brain. Radioactivity was excreted mainly in the faeces when administered to the rat and to a higher extent in the urine after treatment of rhesus monkeys.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3240764     DOI: 10.1007/BF03189938

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  11 in total

1.  Effect of lisuride and LSD on monoamine synthesis after axotomy or reserpine treatment in rat brain.

Authors:  W Kehr; W Speckenbach
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978 Jan-Feb       Impact factor: 3.000

2.  [Inhibition of lactation by N-(D-6-methyl-8-isoergolin-1-yl)-N',N'-diethylurea (VUFB-6638)].

Authors:  M Ausková; K Rezábek; V Zikán; M Semonský
Journal:  Experientia       Date:  1974-04-15

3.  Pharmacokinetics and pharmacodynamics of mepindolol sulphate.

Authors:  J Bonelli; G Hitzenberger; W Krause; H Wendt; U Speck
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1980-04

4.  Pharmacokinetics and pharmacodynamics of the ergot derivative, transdihydrolisuride, in man.

Authors:  W Krause; R Dorow; B Nieuweboer; S H Hasan
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  Dual action on central dopamine function of transdihydrolisuride, a 9, 10-dihydrogenated analogue of the ergot dopamine agonist lisuride.

Authors:  H Wachtel; R Dorow
Journal:  Life Sci       Date:  1983-01-24       Impact factor: 5.037

6.  Pharmacokinetics of proterguride in rat and cynomolgus monkey.

Authors:  W Krause; M Hümpel
Journal:  Xenobiotica       Date:  1988-01       Impact factor: 1.908

7.  The pharmacokinetics and biotransformation of 14C-lisuride hydrogen maleate in rhesus monkey and in man.

Authors:  M Hümpel; W Krause; G A Hoyer; H Wendt; G Pommerenke
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Oct-Dec       Impact factor: 2.441

8.  Prolactin-lowering effect of low doses of lisuride in man.

Authors:  R Horowski; H Wendt; K J Gräf
Journal:  Acta Endocrinol (Copenh)       Date:  1978-02

9.  The pharmacokinetics of lisuride hydrogen maleate in rat, rabbit and rhesus monkey.

Authors:  M Humpel; T Toda; N Oshino; G Pommerenke
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1981       Impact factor: 2.441

10.  Radioimmunoassay of plasma lisuride in man following intravenous and oral administration of lisuride hydrogen maleate: effect on plasma prolactin level.

Authors:  M Hümpel; B Nieuweboer; S H Hasan; H Wendt
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.